Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors (French, HTML)

View metadata and access the original French HTML file: Switching a medicinal ingredient from prescription to non-prescription status draft guidance document: Assessing PDL principles and factors.

Format

HTML

Access

file-only

Publisher-reported update

2023-11-01

This document includes guidance for companies (applicants) who wish to put forward submissions/applications to request a switch of an ingredient from prescription to non-prescription status.

Access original file